The potent photodynamic properties of hypericin (HY) elicit a range of ligh
t-dependent virucidal and tumoricidal activities. Yet, a relatively low red
uction/oxidation potential endows HY with electron accepting and donating p
roperties enabling it to act as both an oxidizing and a reducing agent. HY
can thus compete as an electron acceptor from bioenergized reduction/oxidat
ion reactions generating its excitation energy for biological activities fr
om physiological reduction/oxidation reactions in the absence of light. Our
studies show that HY can inhibit the growth of highly metastatic murine br
east adenocarcinoma and squamous cell carcinoma tumors in culture. Furtherm
ore, we show that HY can interfere with the growth of these tumors in mice
reducing tumor size and prolonging animal survival in complete absence of l
ight. While there is no evidence that HY induces apoptosis in these cells i
n the dark, H-3-thymidine incorporation into DNA was significantly reduced
indicating effects that are apparently cytostatic in nature compared to the
cytocidal effects of HY with light.